| Product NDC: | 24987-249 |
| Proprietary Name: | LANOXIN |
| Non Proprietary Name: | digoxin |
| Active Ingredient(s): | .25 mg/1 & nbsp; digoxin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 24987-249 |
| Labeler Name: | Covis Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020405 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120930 |
| Package NDC: | 24987-249-55 |
| Package Description: | 100 TABLET in 1 BOTTLE (24987-249-55) |
| NDC Code | 24987-249-55 |
| Proprietary Name | LANOXIN |
| Package Description | 100 TABLET in 1 BOTTLE (24987-249-55) |
| Product NDC | 24987-249 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | digoxin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120930 |
| Marketing Category Name | NDA |
| Labeler Name | Covis Pharmaceuticals, Inc. |
| Substance Name | DIGOXIN |
| Strength Number | .25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |